Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an accepted
alternative to transvenous (TV) ICD to provide defibrillation therapy to treat life-threatening …

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a valuable alternative to
the conventional trans-venous ICD (TV-ICD) for the prevention of sudden cardiac death …

Background Current evidence describing the characteristics of subcutaneous implantable
cardioverter-defibrillator (S-ICD) therapy, its trend, and perioperative outcomes compared …

Background Subcutaneous implantable cardioverter defibrillators (S-ICD) have become
more widely available. However, comparisons with conventional transvenous ICDs (TV-ICD) …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …

Implantable cardioverter defibrillators (ICDs) have become a mainstay of treatment in
patients at risk for sudden cardiac death. The majority of contemporary ICDs are implanted …

Background Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an innovative
and less invasive alternative to transvenous ICD (TV-ICD) in selected patients. We aimed to …

Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival
in patients at risk for sudden cardiac death, but complications remain an important …

Background PRAETORIAN is the first randomized controlled trial that demonstrated the
noninferiority of subcutaneous ICD (S‐ICD) in comparison with transvenous ICD (TV‐ICD) …

The difference between subcutaneous implantable cardioverter defibrillators (S-ICDs) and
transvenous ICDs (TV-ICDs) concerns a whole extra thoracic implantation, including a …